CRISPR Medicine News, 8 January 2021 | Your missing links are here - CRISPR Medicine

Call for Papers:

Frontiers in Genome Editing

Open for submissions:

Abstract Deadline: 2nd January 2021

Final Manuscript Deadline: 2nd May 2021


Your Missing Links are Here

Top Picks


  • A new electrochemical microfluidic biosensor has improved detection of microRNAs (miRNAs) that are increasingly used for diagnostics. The new multiplexed CRISPR-Biosensor X divides the biochip's previous single channel into subsections allowing for the amplification-free and simultaneous quantification of up to eight miRNAs.
  • Phages are the principal target of the adaptive immune system, namely CRISPR, that bacteria and archaea developed as protection from foreign DNA. Studying the CRISPR-Cas spacers in Pseudomonas aeruginosa, researchers now confirm that the system also targets closely related prokaryotic species and that CRISPR acts as an important constraint to horizontal gene transfer.
  • Researchers have used CRISPR-Cas9 to quickly validate findings from genome-wide association studies (GWASs) that screen large populations for genetic variants linked to a disease or other phenotype. A GWAS study pointed to a putative enhancer element for the gene PRPF38A involved in bone cell formation. When CRISPR-Cas9 was used to delete this sequence, symptoms of a kind of osteoporosis were alleviated.
  • A new study sheds light on CRISPR-Cas9 editing dynamics in different conditions, including cell types and delivery methods. Among the results, the researchers find that the kinetics of AAV6-mediated homology-directed repair (HDR) deletions are inferior to non-homologous end-joining (NHEJ).



  • A new test for the rapid detection of Sars-CoV-2 specific RNA has been developed by Jennifer Doudna's lab and is posted on the medRxiv* server. The test is called DISCoVER (DiagnosticS with Coronavirus Enzymatic Reporting) and uses viral nucleic acid amplification and Cas13-mediated detection without RNA extraction.

Reviews and Roundups



Heh, huh, wow

Career CRISPR Medicine

Thank you for now - more great reads are on the way!

And if you have questions or suggestions, you can reach out to us directly at We love hearing from readers!

Happy Reading!


p.s. You can follow CRISPR Medicine News on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up for our newsletter yourself here.


CRISPR QC pioneers streamlined and automated CRISPR quality control tools to accelerate research while improving accuracy and performance.


Welcome to CRISPR Cuts, Synthego’s official podcast dedicated to the world of genome engineering. We are in an age of CRISPR revolution! This cutting-edge genome editing technology is quickly becoming a part of our daily conversation and lives, impacting our healthcare, the food we eat, and the materials we use.